|
WO2021049587A1
|
|
Composition for enhancing effect of antibody drug
|
|
JP2020031580A
|
|
HIGH β-GLUCAN PRODUCING STRAINS, β-GLUCAN MANUFACTURING PROCESSES AND METHODS FOR SCREENING HIGH β-GLUCAN PRODUCING STRAINS
|
|
KR20190083699A
|
|
Composition for promoting thrombospondin 1 gene expression
|
|
JP2018002688A
|
|
Composition for enhancing thrombospondin-1 gene expression
|
|
JP2017171590A
|
|
Hematopoietic function promoting composition, and anemia preventive and/or improving compositions
|
|
JP2015136310A
|
|
METHOD FOR PRODUCING β-GLUCAN
|
|
JP2015081239A
|
|
Fat accumulation inhibitor
|
|
JP2012126657A
|
|
Composition and method for preventing and treating mastitis
|
|
EP2508190A1
|
|
Macrophage phagocytosis-activating composition and/or composition promoting cytokine production in macrophages
|
|
TW201119661A
|
|
Therapectic agent for influenza virus infection
|
|
US2010068184A1
|
|
Living body healing accelerator
|
|
JP2006075076A
|
|
COMPOSITION CONTAINING beta-GLUCAN, METHOD FOR PRODUCING THE SAME, AND FOOD AND DRINK OR MOISTURIZING AGENT FOR SKIN CONTAINING THE COMPOSITION
|
|
US2005272694A1
|
|
Composition containing beta-glucan and constipation-relieving drug, immunopotentiatior, and skin moistening agent using the composition
|
|
JP2005220065A
|
|
Immunopotentiator
|
|
JP2004269407A
|
|
Constipation ameliorant and food and beverage containing the same
|
|
JP2004269408A
|
|
Humectant for skin
|
